Research And Markets Research And Markets
0 CHECKOUT

RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update

  • ID: 1196689
  • August 2016
  • Region: Global
  • Bioseeker
1 of 2

Potentially any disease-causing gene, cell type or tissue can be targeted with miRNA, RNAi or siRNA, including those not ’druggable’ with small molecules or protein-based therapies.

There are today 103 companies plus partners developing 131 RNA (miRNA, RNAi & siRNA) drugs in 198 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 39 drugs. Rna (Mirna, Rnai & Sirna) Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 103 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 72 out of the 74 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information. All drugs targets are further categorized on in the software application by 37 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature READ MORE >

Note: Product cover images may vary from those shown
2 of 2



Delivery Format: Desktop App plus Online Access to Updates (One Year)

Note: Product cover images may vary from those shown
3 of 2
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db